MRESVIA (respiratory syncytial virus vaccine, preF protein, mRNA/PF)
RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE·RESPIRATORY SYNCYTIAL VIRUS PNEUMONIA PREVENTION
MODERNA US, INC
Indication
Respiratory syncytial virus pneumonia prevention
Respiratory syncytial virus pneumonia prevention refers to prophylactic strategies aimed at averting lower respiratory tract parenchymal infection caused by respiratory syncytial virus (RSV). Read more about Respiratory syncytial virus pneumonia prevention
11 drugs 8 manufacturers
Drugs that treat it
Common Respiratory syncytial virus pneumonia prevention therapies.
ENFLONSIA (clesrovimab-cfor)
ANTIVIRAL MONOCLONAL ANTIBODIES·RESPIRATORY SYNCYTIAL VIRUS PNEUMONIA PREVENTION
Merck Sharp & Dohme
Filter & compare in the drug finder →Opens the drug finder with Respiratory syncytial virus pneumonia prevention preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRespiratory syncytial virus pneumonia prevention refers to prophylactic strategies aimed at averting lower respiratory tract parenchymal infection caused by respiratory syncytial virus (RSV).
RSV pneumonia primarily impacts vulnerable populations, notably neonates, premature infants, older adults, and immunocompromised individuals, by causing viral replication and severe inflammatory injury within the alveoli and terminal bronchioles.
Pathophysiologically, the disease is characterized by epithelial cell necrosis, inflammatory exudate, alveolar consolidation, and impaired gas exchange, clinically manifesting as tachypnea, severe cough, hypoxia, and respiratory distress.
Preventive measures mitigate these complications by inhibiting viral entry and replication before the pathogen can progress from the upper airways to deep pulmonary tissues.
- fda.gov
Respiratory syncytial virus pneumonia prevention refers to prophylactic strategies aimed at averting lower respiratory tract parenchymal infection caused by respiratory syncytial virus (RSV)
- ncoa.org
Respiratory syncytial virus pneumonia prevention refers to prophylactic strategies aimed at averting lower respiratory tract parenchymal infection caused by respiratory syncytial virus (RSV) RSV pneumonia primarily impacts vulnerable populations, notably neonates, premature infants, older adults, and immunocompromised individuals, by causing viral replication and severe inflammatory injury within the alveoli and terminal bronchioles Preventive measures mitigate these complications by inhibiting ...
- nih.gov
RSV pneumonia primarily impacts vulnerable populations, notably neonates, premature infants, older adults, and immunocompromised individuals, by causing viral replication and severe inflammatory injury within the alveoli and terminal bronchioles
- nih.gov
RSV pneumonia primarily impacts vulnerable populations, notably neonates, premature infants, older adults, and immunocompromised individuals, by causing viral replication and severe inflammatory injury within the alveoli and terminal bronchioles Preventive measures mitigate these complications by inhibiting viral entry and replication before the pathogen can progress from the upper airways to deep pulmonary tissues
- mayoclinic.org
Pathophysiologically, the disease is characterized by epithelial cell necrosis, inflammatory exudate, alveolar consolidation, and impaired gas exchange, clinically manifesting as tachypnea, severe cough, hypoxia, and respiratory distress
- who.int
Pathophysiologically, the disease is characterized by epithelial cell necrosis, inflammatory exudate, alveolar consolidation, and impaired gas exchange, clinically manifesting as tachypnea, severe cough, hypoxia, and respiratory distress
Personalize your experience
Follow Respiratory syncytial virus pneumonia prevention and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.